Resistance to Third-Generation Cephalosporins and Other Antibiotics by Enterobacteriaceae in Western Nigeria

被引:7
|
作者
Okesola, A. O. [1 ]
Makanjuola, O. [1 ]
机构
[1] Univ Ibadan, Univ Coll Hosp, Coll Med, Dept Med Microbiol & Parasitol, Ibadan, Nigeria
关键词
Enterobacteriaceae; third-generation cephalosporins; resistance;
D O I
10.3844/ajidsp.2009.17.20
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Problem statement: The emergence and spread of resistance to third-generation cephalosporins are threatening to create species resistant to all currently available agents. The most common cause of bacterial resistance to beta-lactam antibiotics is the production of beta-lactamases and many of the 2nd and 3rd-generation penicillins and cephalosporins were specifically designed to resist the hydrolytic action of major beta-lactamases. However new beta-lactamases emerged against each of the new classes of beta-lactams that were introduced and caused resistance. This study was designed to determine the rate of resistance to 3rd-generation cephalosporins and other classes of antibiotics by the Enterobacteriaceae in this environment. Approach: One hundred bacteria isolates belonging to the family Enterobacteriaceae identified from different clinical specimens between October and December 2007 using standard bacteriological methods. These were subjected to antibiotic susceptibility testing to third-generation cephalosporins and other classes of antibiotics which included quinolones and an aminoglycoside using the Kirby-Bauer method of disc diffusion test. Results: Out of the total number of Enterobacteriaceae isolated in the study period, only 54.8% of the klebsiella species isolated were sensitive to ceftazidime, 48.4% to ceftriaxone and 30.7% to cefotaxime. With Escherichia coli however, the susceptibility pattern to the 3rd-generation cephalosporins was better (65.6% were sensitive to ceftazidime, 62.5% to ceftriaxone and 71.9% to cefotaxime). In proteus species, the susceptibility pattern was generally poor to the three classes of antibiotics(50% were sensitive to ceftazidime and ceftriaxone, 0% to cefotaxime, 33.3% to ciprofloxacin, 50% to gentamycin and 0% to amoxycillin/clavulanate). Conclusion/Recommendations: The poor susceptibility to amoxicillin/clavulanate demonstrated by all the isolates in this study showed the probability of new beta-lactamases production. Further studies therefore need to be done in this environment to determine the types of the beta-lactamases produced by the Enterobacteriaceae here, the prevalent rate of such isolates and the molecular analysis of the new beta-lactamases produced.
引用
收藏
页码:17 / 20
页数:4
相关论文
共 50 条
  • [1] Antimicrobial co-resistance among Enterobacteriaceae resistant or susceptible to third-generation cephalosporins
    Fujita, T.
    Asahata, S.
    Ainoda, Y.
    Hirai, Y.
    Goto, A.
    Totsuka, K.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 : S60 - S60
  • [2] Nursing home residents and Enterobacteriaceae resistant to third-generation cephalosporins
    Sandoval, C
    Walter, SD
    McGeer, A
    Simor, AE
    Bradley, SF
    Moss, LM
    Loeb, MB
    EMERGING INFECTIOUS DISEASES, 2004, 10 (06) : 1050 - 1055
  • [3] Resistance of third-generation cephalosporins in Laribacter hongkongensis
    Wen, S. X.
    Wu, M. Z.
    Feng, D. H.
    Chen, D. Q.
    Yang, L.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 125 : 4 - 5
  • [4] Evolution of acquired resistance to third-generation cephalosporins in Enterobacteriaceae in a Tunisian hospital 1993-2001
    Boutiba-Ben Boubaker, I
    Ghozzi, R
    Ben Abdallah, H
    Mamlouk, K
    Kamoun, A
    Ben Redjeb, S
    CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (07) : 665 - 667
  • [5] RESISTANCE TO THIRD GENERATION CEPHALOSPORINS IN CLINICAL STRAINS OF ENTEROBACTERIACEAE
    AVRAMOVA, R
    KEULEYAN, E
    EKIMOVA, E
    JOURNAL OF CHEMOTHERAPY, 1993, 5 : 262 - 264
  • [6] Evaluation of the βLacta Test, a Rapid Test Detecting Resistance to Third-Generation Cephalosporins in Clinical Strains of Enterobacteriaceae
    Renvoise, Aurelie
    Decre, Dominique
    Amarsy-Guerle, Rishma
    Huang, Te-Din
    Jost, Christelle
    Podglajen, Isabelle
    Raskine, Laurent
    Genel, Nathalie
    Bogaerts, Pierre
    Jarlier, Vincent
    Arlet, Guillaume
    JOURNAL OF CLINICAL MICROBIOLOGY, 2013, 51 (12) : 4012 - 4017
  • [7] Third-generation oral cephalosporins
    Kraeft, H
    INTERNIST, 1996, 37 (03): : 319 - 323
  • [8] Should third-generation cephalosporins be avoided against AmpC-inducible Enterobacteriaceae?
    Livermore, DM
    Brown, DFJ
    Quinn, JP
    Carmeli, Y
    Paterson, DL
    Yu, VL
    CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (01) : 84 - 85
  • [9] Population Distribution of Beta-Lactamase Conferring Resistance to Third-Generation Cephalosporins in Human Clinical Enterobacteriaceae in The Netherlands
    Voets, Guido M.
    Platteel, Tamara N.
    Fluit, Ad C.
    Scharringa, Jelle
    Schapendonk, Claudia M.
    Stuart, James Cohen
    Bonten, Marc J. M.
    Leverstein-van Hal, Maurine A.
    PLOS ONE, 2012, 7 (12):
  • [10] Increasing Resistance to Third-Generation Cephalosporins in Spontaneous Bacterial Peritonitis
    Tripathi, Nishant
    Koirala, Niki
    Kato, Hirotaka
    MAYO CLINIC PROCEEDINGS, 2020, 95 (04) : 828 - 829